News

The Eurêka Foundation – the beneficiary – is an integral part of ArchiMed’s mission to sustainably improve lives as an impact investor. November 5, 2020 – Global private equity healthcare specialist ArchiMed announces its latest contribution of several million euros to the Eurêka Foundation, the philanthropy created by its partners when the firm was founded in…

Investment to accelerate NAMSA’s global growth and strategic vision; NAMSA is the third acquisition of MED Platform I, ArchiMed’s recently closed €1 billion mid-cap buy-and-build fund for the healthcare sector.   September 1, 2020 – Private equity healthcare specialist ArchiMed has acquired from the founding Gorski Family a majority stake in NAMSA, the only full…

The oversubscribed fund closed above the global private equity healthcare specialist’s €800 million target, notwithstanding the impact of the Covid-19 pandemic. ArchiMed’s €1 billion ($1.2 billion) mid-market buy-and-build fund, MED Platform I, attracted major commitments from a broad range of institutional investors and family offices in both Europe (70 percent) and North America (30 percent).…

ArchiMed’s purchase will accelerate ActiGraph’s expansion within the complex, highly regulated global drug development industry. Private equity healthcare specialist, ArchiMed has acquired ActiGraph, a pioneering developer of wearable, remote monitoring technology for academic studies and drug trials. ActiGraph’s mobility and sleep tracking hardware, software and analysis solutions are the most widely used research-grade monitoring systems…

NorthEdge drives 3x return on cross-border DHG sale – NorthEdge Capital has completed the sale of Direct Healthcare Group (DHG) in a secondary buyout by European healthcare specialist investor ArchiMed. The deal sees NorthEdge secure a 3x return on its initial investment, with an IRR of 39 per cent. NorthEdge led a management buyout of…

ArchiMed, European private equity healthcare specialist, announces successful growth of its portfolio company Micromed into Neurodiagnostics – on both sides of the Atlantic. Archimed expands neurodiagnostic business in Europe and the US Portfolio Company, Micromed, a European-based neurodiagnostic system manufacturer has moved to direct sales in the United States and its wholly owned subsidiary, US based Moberg…